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We propose a dynamic mathematical model of tissue oxygen transport by a preexisting three-dimensional microvascular network
which provides nutrients for an in situ cancer at the very early stage of primary microtumour growth. The expanding tumour
consumes oxygen during its invasion to the surrounding tissues and cooption of host vessels. The preexisting vessel cooption,
remodelling and collapse are modelled by the changes of haemodynamic conditions due to the growing tumour. A detailed
computational model of oxygen transport in tumour tissue is developed by considering (a) the time-varying oxygen advection
diffusion equation within the microvessel segments, (b) the oxygen flux across the vessel walls, and (c) the oxygen diffusion and
consumptionwithin the tumour and surrounding healthy tissue.The results show the oxygen concentration distribution at different
time points of early tumour growth. In addition, the influence of preexisting vessel density on the oxygen transport has been
discussed.The proposedmodel not only provides a quantitative approach for investigating the interactions between tumour growth
and oxygen delivery, but also is extendable to model other molecules or chemotherapeutic drug transport in the future study.
1. Introduction
There are a lot of controversies about exactly how a tumour
is initiated, but it is generally known that the interac-
tions between tumour cells with the host microenvironment
have played a predominant role in the pathophysiological
mechanisms of tumourigenesis and progression. Hypoxia is
believed to be one of the important hallmarks of the abnormal
metabolic microenvironments in malignant tumours [1].
Since the diffusion limit of oxygen in tissue is 100–200𝜇m
[2], the regions far from blood vessels become hypoxic.
However, many cancers growing in a blood-supply-sufficient
environment, such as breast cancer and glioma, were also
found to form the hypoxic region in foci. This suggests
that tumour blood vessels fail to provide adequate levels of
oxygen for the proliferating tumour cells. A key reason for
this phenomenon is the abnormal architecture and function
of tumour microvasculature, including the heterogeneous
spatial distribution, the uneven vessel diameters, the leaky
vessel wall, the poor blood perfusion, and the low level
of red blood cell (RBC) velocity [3]. The heterogeneity of
tumour blood flow due to the disorganized, dysfunctional
microvasculature causes hypoxic region in tumour tissue
despite the presence of blood flow.
Hypoxic tumour cells can express high levels of angio-
genic regulators including vascular endothelial growth factor
(VEGF). The new vasculature in response to the upregulated
angiogenic factors provides essential nutrients for rapid neo-
plastic expansion of tumours [4]. Except this generally known
mechanism of neovasculature, the “cooption” of preexisting
vessel network also plays a significant role in early tumour
progression [5]. Holash et al. [5] studied early angiogenic
events using the rat C6 gliomamodel.The results showed that
even the smallest C6 gliomas at just 1 week after implantation
was well vascularized by coopting of preexisting blood
vessels. Further experiments [6–8] revealed that when a small
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amount of tumour cells was implanted into healthy tissue,
they managed to coopt and migrate along host vessels, as
well as producing many chemical substances, such as VEGF,
Ang-1, and Ang-2, to change the microenvironment around
the host vessels, which can induce immature changes in the
host tissue vasculature, including vessel dilation, increased
capillary permeability, and tortuosity [9]. The local microen-
vironment especially the oxygen concentration distribution
is important in the switch from preexisting vessel cooption
to angiogenic vascularization. Detailedmathematical models
are needed to provide an analysis framework not only to
quantify physiological parameters such as tissue oxygen
diffusion and vessel wall oxygen permeability that are not
directly measurable, but also to handle the dynamic oxygen
delivery processes.
Mathematical models for oxygen transport in capillary-
perfused tissue have been studied extensively from last
century. As a famous pioneering study, Krogh [2] presented a
simple model to describe oxygen delivery through uniformly
spaced parallel capillaries and considered a single capillary
and its surrounding tissue as a cylinder region. Since it is
difficult to measure the tissue oxygen concentration in three-
dimensions with a micron resolution experimentally, more
and more mathematical modellings and simulations have
been proposed to obtain a better quantitative understand-
ing in the microvascular oxygen transport. Goldman et al.
published a series of work [10–12] on oxygen delivery in
skeletal muscle, which have shown the importance of many
features neglected in theKroghmodel, including the capillary
tortuosity and anastomoses, nonlinear oxygen consumption
in tissue, myoglobin-facilitated diffusion and nonlinear oxy-
hemoglobin dissociation in theRBCs andplasma.Theirmod-
els include a detailed description of intravascular resistance
to oxygen transport and are capable of incorporating real-
istic three-dimensional microvascular network geometries.
Secomb et al. [13] developed a theoretical model based on
a Green’s function approach, for realistic three-dimensional
network geometries derived from observations of skeletal
muscle, brain, and tumour tissues. However, the influences of
haemodynamics conditions on the oxygen delivery are poorly
considered in the above models.
For the modelling of oxygen delivery in tumours, oxygen
concentration field is generally introduced to simulate the
dynamic interactions of tumour cells with the surround-
ing tissues, by considering one or more pathophysiological
characteristics during the process of malignant tumours
growth. The reaction-diffusion equation is often used to
describe the distribution of oxygen concentration. However,
the source term of the equation is difficult to handle without
the inclusion of preexisting vessels. Anderson [14] assumed
that oxygen production is proportional to the density of
extracellular matrix (ECM). Some other studies [15, 16]
included the production of oxygen only from the simulation
region boundary as constant oxygen source, while the oxygen
can only be used by tumour cells and transported by diffusion
from the boundary. In our previous coupled model [17], the
oxygen supply by microvessels was assumed to be a linear
function of local blood haematocrit, which is a rough way to
deal with the oxygen transport through vessel network.These
models may be useful for the study of tumour cell growth
in a given nutrient environment; they cannot provide the
dynamic oxygen supply variation caused by the preexisting
vessel network adaptation to tumour growth and its influence
on tumour growth.
Themain aim of this study is to establish a dynamicmath-
ematical model of tissue oxygen transport by a preexisting
three-dimensional microvascular network which provides
nutrients for an in situ cancer at the very early stage of
primarymicrotumour growth. At the same time, the expand-
ing tumour will consume oxygen during its invasion to the
surrounding tissues and cooption of host vessels. In addition,
the preexisting vessel cooption, remodelling, and collapse are
modelled by the changes of haemodynamic conditions due to
the growing tumour. Based on our previous haemodynamical
calculation in solid tumour [18], we develop a detailed
computationalmodel of oxygen transport in tumour tissue by
considering (a) the time-varying oxygen advection diffusion
equation within the microvessel segments, (b) the oxygen
flux across the vessel walls, and (c) the oxygen diffusion and
consumption within the tumour and surrounding healthy
tissue. The current model will provide a framework for ana-
lyzing the dynamic responses of local oxygen environment to
the early avascular tumour growth and host vessel cooption,
and will enable us to study quantitatively the influence of
oxygen transport on the initiation of primary microtumours
by preexisting vessel cooption.
2. Method
In this section, we first describe the generation of initial
preexisting vessel network in the model (Section 2.1). The
haemodynamic calculation through the 3Dmicrovasculature
is explained in Section 2.2. The oxygen transport as well as
other chemicals is modelled based on the obtained haemo-
dynamic information (Section 2.3). The tumour growth and
microvessels are coupled by the changes of haemodynamic
and chemical environments. It is based on the facts as follows:
(a) the dynamic changes of tumourmicrovessels influence the
chemical environments especially the oxygen supply, which
determine the behavior of tumour cells (Section 2.4) and (b)
the changes of haemodynamic and chemical environments
due to the growing tumour induce tumour vessel dilation,
cooption, remodelling, and collapse (Section 2.5). The sim-
ulation algorithm is summarized in Section 2.6.
2.1. Preexisting Vessel Network. For the morphological anal-
ysis we consider vessel segments within a cube simulation
domain Ω of 1mm3. A basic grid of 100 × 100 × 100 is
generated uniformly in the cube with a distance of 10 𝜇m
between the neighbouring nodes (Figure 1). The preexisting
vasculature we designed in the basic model has a typical
pattern of a normal arteriolar network. Parallel arterioles are
distributed along 𝑦 axis with uniform distance of 10 grids,
that is, 100 𝜇m. Three orders with different vessel diameters
are defined to reflect the heterogeneous characteristic of these
arterioles. The vessel diameter and proportion of each order
are shown in Table 1. In addition, capillaries are designed
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Figure 1: (a) 3D preexisting microvascular network with typical pattern of a normal arteriolar network, including parallel distributed vessels
with varying vessel diameter and capillaries for cross link. (b) The enlarged view of local microvascular network. Different colours represent
different orders of arterioles and capillaries (arterioles order 1: black; arterioles order 2: blue; arterioles order 3: green; capillaries: red).
Table 1: Vessel diameter and proportion of three orders of arterioles
and capillaries in the model.
Vessel diameter (𝜇m) Proportion
Arterioles
Order 1 50 10%
Order 2 30 20%
Order 3 10 70%
Capillaries 8 NaN
stochastically as cross links between the arterioles, having
diameters of 8 𝜇m.
2.2. Haemodynamic Calculation. The haemodynamic model
in this study is based on our previous work on the coupled
modelling of intravascular blood flow with interstitial fluid
flow [18, 22]. Briefly, the basic equation for the intravascular
blood flow is the flux concentration and incompressible flow
at each node. Flow resistance is assumed to follow Poiseuille’s
law in each vessel segment. The interstitial fluid flow is
controlled by Darcy’s law. The intravascular and interstitial
flow is coupled by the transvascular flow, which is described
by Starling’s law. Blood viscosity is considered according to
function of vessel diameter, local haematocrit, and plasma
viscosity. In addition, vessel compliance and wall shear stress
are correlated to vessel remodelling and vessel collapse,
respectively, which will be explained in details in Section 2.5.
The main equations for blood flow calculation are as
follows:
𝑄V =
𝜋𝑅
4
Δ𝑃V
8𝜇Δ𝑙
,
𝑄
𝑡
= 2𝜋𝑅 ⋅ Δ𝑙 ⋅ 𝐿
𝑝
(𝑃V − 𝑃𝑖 − 𝜎𝑇 (𝜋V − 𝜋𝑖)) ,
𝑄 = 𝑄V − 𝑄𝑡,
(1)
where 𝑄 is the flow rate of each vessel segment, which
amounts to zero at each node of the vessel network due to
the assumption of flux conservation and incompressible flow.
𝑄V is the vascular flow rate without fluid leakage; 𝑄𝑡 is the
transvascular flow rate. Δ𝑙 and 𝑅 are the length and radius
of vessel segment. 𝑃V and 𝑃𝑖 are the intravascular pressure
and the interstitial pressure of the vascular element.The total
difference of 𝑃V from plane 𝑦 = 100 to 𝑦 = 0 is set to be
3.5mmHg as the driving force of blood in the network (or
the boundary condition). 𝐿
𝑝
is the hydraulic permeability of
the vessel wall. 𝜎
𝑇
is the average osmotic reflection coefficient
for plasma proteins;𝜋V and𝜋𝑖 are the colloid osmotic pressure
of plasma and interstitial fluid.
The velocity of intravascular and interstitial flow satisfies
𝑈V =
𝑄
𝜋𝑅2
,
𝑈
𝑖
= −𝐾∇𝑃
𝑖
,
∇ ⋅ 𝑈
𝑖
=
𝐿
𝑝
𝑆
𝑉
(𝑃V − 𝑃𝑖 − 𝜎𝑇 (𝜋V − 𝜋𝑖)) ,
(2)
where 𝑈V and 𝑈𝑖 are the intravascular flow velocity and
the interstitial flow velocity, respectively; 𝐾 is the hydraulic
conductivity coefficient of the interstitium; 𝑆/𝑉 is the surface
area per unit volume for transport in the interstitium.
The distribution of red blood cells (RBCs) at microvascu-
lar bifurcation is calculated based on the approach proposed
by Pries and Secomb [23]. The details of blood rheology
simulation were described in Wu et al. [22].
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From the haemodynamic simulation, we are able to
obtain the intravascular flow velocity𝑈V and the hematocritic
𝐻 in the microvessel network which are used in oxygen
concentration calculation and vessel diameter which is used
to estimate vessel remodelling and collapse.
2.3. Oxygen Concentration Calculation. The glioma cell and
endothelial cell behaviours are coupled by the changes of the
chemicals in the extracellular matrix (ECM), such as oxygen
and matrix degradation enzymes (MDEs). The transport
of these chemicals (oxygen and MDEs) is modelled by
quasisteady reaction-diffusion equations.The ECM is treated
as a continuum substance and can be degraded by MDEs,
while the MDEs are governed by diffusion, produced by TCs
and ECs, and decay of itself. The equations describing the
interactions of TCs and ECs with ECM and MDE are
𝜕𝐶
𝑓
𝜕𝑡
= −𝛿𝐶
𝑚
𝐶
𝑓
.
𝜕𝐶
𝑚
𝜕𝑡
= 𝐷
𝑚
∇
2
𝐶
𝑚
+ 𝜇
𝑇
TC
𝑖,𝑗
+ 𝜇
𝐸
EC
𝑖,𝑗
− 𝜆𝐶
𝑚
,
(3)
where 𝐶
𝑓
and 𝐶
𝑚
are the ECM and MDE concentration,
separately. The TC
𝑖,𝑗
and EC
𝑖,𝑗
terms represent a tumour cell
and an endothelial cell located at a node position (𝑖, 𝑗). Their
values are either 1 if a cell is present or 0 if it is not. 𝐷
𝑚
is
MDE diffusion coefficient, and, 𝛿, 𝜇
𝑇
, 𝜇
𝐸
, and 𝜆 are positive
constants.
To obtain more realistic oxygen concentration field, the
advection and diffusion of oxygen in the vessel network are
introduced [20]. The computational space is separated into
three domains to characterize three distinct physiological
processes, which are the oxygen advection equation inside
the vessel, the oxygen flux across the vessel wall and the free
oxygen diffusion in the tissue.
Specifically, the oxygen transport inside the vessel is
represented by the advection equation
𝜕𝐶o F
𝜕𝑡
= −
󳨀⇀
𝑈V ⋅ ∇𝐶o F,
𝜕𝐶o B
𝜕𝑡
= −
󳨀⇀
𝑈V ⋅ ∇𝐶o B,
(4)
where 𝐶o F and 𝐶o B are the free and bounded oxygen
concentrations, respectively. 󳨀⇀𝑈V denotes the intravascular
blood velocity.
The equation between the hemoglobin bound oxygen and
free oxygen is
𝐶o B = 4𝐻 ⋅ 𝐶Hb ⋅ SO2 (𝐶o F) , (5)
where 𝐻 denotes haematocrit obtained from the haemo-
dynamic calculation; 𝐶Hb is the haemoglobin concentration
within a red blood cell; SO
2
(𝐶o F) is the haemoglobin oxygen
saturation.
The free oxygen flux across the vessel wall satisfies Fick’s
law:
𝜕𝐶o F
𝜕𝑡
𝑉 = 𝐽 ⋅ 𝐴, (6)
where𝑉 and𝐴 are the tissue volume and the associated vessel
wall area. 𝐽 is the oxygen flux which is obtained by
𝐽 = −𝐿
𝑝
(𝐶
ex
o F − 𝐶
in
o F)
𝛼𝑤
, (7)
where 𝐶exo F and 𝐶
in
o F are the free oxygen concentrations at
the exterior and interior surfaces of the vessel, respectively;
𝛼 is the Bunsen solubility coefficient; 𝑤 is the vessel wall
thickness. 𝐿
𝑝
is the vessel wall permeability which is varied
in different maturity level of vessel segments.
The interstitial fluid velocity is very slow due to the low
interstitial pressure gradient in the tumour region. In fact,
𝑈
𝑖
is almost 100 times smaller than 𝑈V in value according to
the simulation results in our previous model. Therefore, we
assume the free oxygen transported through the tissue space
is governed by the oxygen diffusion equation which is not
influenced by the interstitial fluid velocity 𝑈
𝑖
.
Consider
𝜕𝐶o F
𝜕𝑡
= ∇ ⋅ (𝐷o∇𝐶o F) − 𝛾TC𝑖,𝑗, (8)
where𝐷o is the tissue oxygen diffusion coefficient and 𝛾 is the
consumption coefficient.
The initial condition of ECM density is set to be 1 and
other chemicals’ concentrations (oxygen and MDEs) are 0.
No-flux boundary conditions are used in the simulation
field. Since chemicals are transported much faster than the
characteristic time for cell proliferation and migration, the
chemicals’ concentrations are solved to steady state at each
time step of the simulation with an inner iteration step of 5 s.
2.4. Tumour Cell Phenotype. The probabilistic hybrid model
for tumour cell growth is based on the previous work [17].
The 3D model is defined on a 100 × 100 × 100 grid to cover a
1mm × 1mm × 1mm volume, so the grid length corresponds
approximately to the size of a tumour cell, that is, 10 𝜇m.
We assumed three different phenotypes of glioma cells:
the proliferating cells (𝑃), the quiescent cells (𝑄), and the
necrotic cells (𝑁). Initially, we put 20 proliferating cells in the
central area. Two thresholds of oxygen concentration for cell
proliferation (𝜃prol) and cell survival (𝜃surv) are introduced to
describe the effects of oxygen field on the tumour cell actions.
To be specific, if there is enough oxygen (𝐶o ≥ 𝜃prol) and a
space available, a tumour cell will proliferate to two daughter
cells with a probability, defined as𝑇age/𝑇TC.𝑇age is the tumour
cell age range from 1 to 𝑇TC and with an incremental 1 in each
simulation time step.𝑇TC is the tumour cell proliferation time
(set to be 9 hour, that is, 6 time steps).This assumptionmeans
an older tumour cell would be more likely to proliferate.
One of the two daughter cells will replace the parent cell and
the other cell will move to the neighbouring element. When
the local oxygen concentration at a tumour site is below the
cell survival threshold 𝜃surv, the tumour cell is marked as
necrotic cells and will not be revisited at the next time step.
The necrotic cells have a probability of 20% to disappear to
form available space for glioma cells and endothelial cells if
they stay necrotic for more than 45 hours (30 time steps).
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Table 2: Parameters of different phenotypes of glioma cells.
Phenotypes MDE production Oxygen consumption
Proliferating cells (P) 𝜇
𝑇
𝛾
Quiescent cells (Q) 𝜇
𝑇
/5 𝛾/2
Necrotic cells (N) 𝜇
𝑇
/10 𝛾/4
When tumour cells satisfy the survival condition but there
is no neighbouring space for them to proliferate, they will go
to quiescent.
Each phenotype of tumour cell has different coefficients
of the consumption rate of oxygen and the production rate of
MDEs [17] (Table 2).
2.5. Vessel Cooption, Remodelling andCollapse. Experimental
and clinical studies both revealed that microvessel diameter
increases in response to growth factors. Do¨me et al. [9] found
that even a single tumour cell can induce radical changes in
the host tissue vasculature in a mouse model of glomeruloid
angiogenesis. In our model, we consider vessel dilation as
the first signal of a preexisting vessel becomes an immature
vessel. A vessel segment surrounded by active tumour cells
will increase its radius 𝑅with the rate 0.4 𝜇m/h if 𝑅 ≤ 𝑅max =
20. At the same time, the permeability of vessel wall 𝐿
𝑝
is
increasing in a dilation vessel and satisfies
𝐿
𝑝
= 𝐿
𝑇
𝑝
(1 −
𝑅max − 𝑅
𝑅max
) , (9)
where 𝐿𝑇
𝑝
represents the vessel permeability value in tumour
tissue.
For a preexist vessel, once vessel dilation occurs, the vessel
segment was treated as an immature vessel and was allowed
to vary in radius in response to the difference between
intravascular pressure and interstitial pressure. The capillary
compliance satisfies the empirical equation of Netti et al. [21]:
𝑅 =
{
{
{
𝑅
0
(
𝑃V − 𝑃𝑖 + 𝑃𝑐
𝐸
)
𝑏
, immature vessel,
𝑅
0
, mature vessel,
(10)
where 𝑅
0
is the origin radius of the capillary; 𝑏 is the
compliance exponent;𝐸 is the compliance coefficient.𝑃
𝑐
is the
collapse pressure and represents the ability of a vessel segment
remaining structure intact under the pressure difference.
Based on the above equation, when the immaturation
level of the vessel segment become more serious, the 𝑃
𝑖
increases due to the higher 𝐿
𝑝
, which can induce vessel
compressing. When vessel radius is compressed to below
zero, the vessel segment collapses. Another factor leading to
vessel collapse in tumours is the apoptosis of endothelial cells
due to the disturbed blood flow or severe reduction of blood
flow rate in the vessel. Wall shear stress (WSS) is used to
estimate this kind of vessel regression, similar to our previous
work [17].TheWSS of a vascular segment 𝑘 can be calculated
as
𝜏 =
Δ𝑃
𝑉
⋅ 𝑅
2Δ𝑙
. (11)
We assume that a circulated vessel, which is surrounded by
the TCs, will collapse with a predefined probability if theWSS
value in the vessel is less than a threshold 𝜏crit = 0.5𝑓0 (𝑓0 is
the meanWSS value of the vessels of Arterioles order 3). The
probability is assumed to be proportional to the duration of
lowWSS in the vessel; that is, the longer the vessel experiences
the low WSS, the more likely the vessel is to collapse if the
criterion is satisfied.
2.6. Simulation Algorithm
Step 0. Initialize.
Step 0.1. Create the 3D preexisting vessel network and
initialize the model parameters.
Step 0.2. Put 20 proliferating cells with random ages from𝑇 =
1 to 𝑇TC in the central area.
Step 0.3. Set up fluid flow boundary conditions.
Step 1. Haemodynamic calculation (see (1)–(2)), and obtain
the flow information.
Step 2. Calculate the chemical’s concentration field.
Step 2.1. Solve (3) to obtain the concentration distribution of
ECM and MDE.
Step 2.2. Solve (4)–(5) to obtain the oxygen transport inside
the vessel using the intravascular blood velocity 󳨀⇀𝑈V and
haematocrit𝐻 from Step 1.
Step 2.3. Solve (6) and (7) to obtain the free oxygen flux across
the vessel wall.
Step 2.4. Solve (8) to obtain the free oxygen transported
through the tissue space.
Step 2.5. Update the oxygen concentration field through the
simulation domain.
Step 3. Determine the behavior of tumour cells according to
the local oxygen concentration, the available space, and the
cell age and update the tumour cell distribution.
Step 4. Update the vessel network.
Step 4.1. Vessel cooption and vessel radius and permeability
changes (see (9)) in immature vessels.
Step 4.2. Vessel remodelling according to (10) update the
radius of vessel segments.
Step 4.3. Certain vessel collapse based on the 𝑅 changing and
WSS criterion (see (11)).
Step 5. Go to Step 1.
Each time step increment (𝑇 = 𝑇 + 1) corresponds to 1.5
hour. We will use nondimensional time unit instead of hours
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Table 3: Parameter values used in the simulation.
Parameter Value Description Reference
Δ𝑙 10𝜇m Lattice constant
𝜎
𝑇
0.82 Average osmotic reflection coefficient for plasma proteins Baxter and Jain (1989) [19]
𝜋V 20mmHg Colloid osmotic pressure of plasma Baxter and Jain (1989) [19]
𝜋
𝑖
15mmHg Colloid osmotic pressure of interstitial fluid Baxter and Jain (1989) [19]
𝐾 4.13 × 10−8 cm2/mmHg s Hydraulic conductivity coefficient of the interstitium Baxter and Jain (1989) [19]
𝑆/𝑉 200 cm−1 Surface area per unit volume for transport in the interstitium Baxter and Jain (1989) [19]
𝐷
𝑚
10−9 cm2s−1 MDE diffusion coefficient Anderson (2005) [14]
𝛿 1.3 × 102 cm3M−1s−1 ECM degradation coefficient Cai et al. (2011) [17]
𝜇
𝑇
1.7 × 10−18Mcells−1s−1 MDE production by TC Cai et al. (2011) [17]
𝜇
𝐸
0.3 × 10−18Mcells−1s−1 MDE production by EC Cai et al. (2011) [17]
𝜆 1.7 × 10−8 s−1 MDE decay coefficient Anderson (2005) [14]
𝛼 1.27 × 10−15 𝜇mol/(𝜇m3mmHg) Bunsen solubility coefficient Fang et al. (2008) [20]
𝐷o 10
−5 cm2s−1 Oxygen diffusion coefficient Anderson (2005) [14]
𝛾 6.25 × 10−17Mcells−1s−1 Oxygen consumption coefficient Anderson (2005) [14]
𝐿
𝑇
𝑝
2.8 × 10−7 cm/mmHg s Vessel permeability in tumour tissue Baxter and Jain (1989) [19]
𝐸 6.5mmHg Vessel compliance coefficient Netti et al. (1996) [21]
𝑏 0.1 Vessel compliance index Netti et al. (1996) [21]
in the following results. All parameters used in the simulation
are summarized in Table 3.
3. Results
3.1. Oxygen Concentration Distribution with Early Tumour
Growth. Figure 2 shows the dynamic processes of oxygen
transport during the tumour growth and invasion. The blue
regions shown in the right column represent the tumour
invasive areas. It is found that the tumour cells generally
grow along the parallel arterioles of the preexisting vessel
network, which can provide sufficient oxygen for tumour
growth. At the same time, the growing tumour undergoes
central necrosis, due to the oxygen consumption of prolif-
erating tumour cells, resulting in the hypoxia in the tumour
invasion region (shown in the left column in Figure 2).
In the current model, the vessel cooption and remodelling
are also considered as key factors to control the dynamic
interactions between preexisting vessels and growing tumour.
With the cooption and remodelling of preexisting vessels
induced by the invasion of tumour cells, some microvessels
become immature and surrounded by tumour cells to be
intratumour vessels. Due to the compression of tumour cells
on the vessel wall and the continuous reduction ofWSS, these
immature vessels (especially capillaries between arterioles)
will undergo collapse. As a consequence, the surrounded
tumour cells becomenecrotic andwill invade to healthy tissue
further, increasing the tumour invasive area and forming
some clusters of surviving tumour cells (shown in the right
column in Figure 2).
3.2. Sensitivity to Preexisting Vessel Network. To access the
sensitivities to the preexisting vascular network, we changed
the microvessel density (MVD) to values of 0.5 time (Case
a) and 1.5 time (Case c) of that in the baseline case (Case b).
The distribution of integrated oxygen concentration 𝑐∗o along
𝑥-axis at plane 𝑧 = 50 in three cases is shown in Figure 3.
The dotted lines show the average oxygen concentrations
through the plane. In the three cases, the average oxygen
concentrations increase with the initial MVD and decrease
with tumour growing. In addition, the reduction of the
average 𝑐∗o is more significant in the less MVD case (Case a)
than that in the baseline (Case b) and more MVD (Case c)
cases, which suggests that the emergence of hypoxia-induced
tumour angiogenesis will be targeted earlier in a blood-
supply-deficient microenvironment.
The oxygen concentration at the central region around
𝑥 = 50 is always below the average 𝑐∗o , which corresponds
to the hypoxia in the tumour center. The hypoxia region
will gradually expand with tumour growth, while the con-
centration gradient of oxygen will reduce at the same time.
This indicates the oxygen concentration distribution in the
modelling region towards equilibrium in the dynamics of
oxygen consumption of tumour growth and oxygen pro-
duction of preexisting vasculature. It is noteworthy that the
oxygen distribution remains substantially unchanged after
𝑇 = 100 in Case c (Figures 3(h) and 3(i)), which suggests
the balance between oxygen consumption and production
emerged earlier in a blood-supply-sufficient microenviron-
ment.
3.3. Flow-Dependent and Flow-Independent Oxygen Trans-
port. In the present study, flow-dependent oxygen transport
was used instead of the simple treatment of oxygen in our
previous studies [24] andmany others in which the vessel was
treated as point source of oxygen. A test case was designed
in which the vessel segment was set as a point source of
oxygen.The statistical results in Figure 4 show the proportion
of oxygen supply to the tumour tissue by every arterioles
order at the end of simulation (𝑇 = 200). Since the point
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Figure 2: The distributions of oxygen concentration (left column) at plane 𝑧 = 50 and the tumour invasion region (right column) from 𝑥-𝑦
view, at 𝑇 = 10 (a), 𝑇 = 50 (b), 𝑇 = 100 (c), and 𝑇 = 150 (d), respectively.
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Figure 3: Distribution of integrated oxygen concentration 𝑐∗o along 𝑥-axis at plane 𝑧 = 50 in three cases of different initial MVD.The dotted
lines represent the average oxygen concentrations. Case b: the baseline model ((d) 𝑇 = 50; (e) 𝑇 = 100; (f) 𝑇 = 150); Case a: a MVD value
of 0.5 time of that in case b ((a) 𝑇 = 50; (b) 𝑇 = 100; (c) 𝑇 = 150); Case c: a MVD value 1.5 times larger than that in case b ((g) 𝑇 = 50; (h)
𝑇 = 100; (i) 𝑇 = 150).
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Figure 4: The proportion of oxygen supply to the tumour tissue by
every arterioles order and capillaries in the basic case and the control
case at 𝑇 = 200.
source of oxygen is only related to the quantity of vessel
segments in the test case, the smallest capillaries with largest
number provide the highest percentage of oxygen (up to
35%). In the basic case, although the number of larger vessels
(arterioles order 1) is the smallest in the four different sized
vessels, the abundant blood perfusion allows them to be
the primary provider of oxygen, but at limited perfusion
locations.There are nonoticeable differences between the two
cases in the final results of tumour growth. However, flow-
dependent oxygen transport can offer more realistic oxygen
concentration field since the blood perfusion is known to be
heterogeneous in the tumour tissue.
4. Discussion and Conclusion
In this work, we have proposed a dynamic mathematical
modelling system to investigate the oxygen transport in
a three-dimensional preexisting vessel network during the
early tumour growth process. A 3D tree-like architecture
network with different arterioles orders for vessel diameter is
generated as preexisting vasculature in host tissue. To obtain
more realistic oxygen concentration field, the advection and
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diffusion of oxygen in the vessel network are introduced.
The computational space is separated into three domains to
characterize three distinct physiological processes, which are
the oxygen advection equation inside the vessel, the oxygen
flux across the vessel wall, and the free oxygen diffusion
in the tissue. The oxygen advection inside the vessel and
the oxygen flux across the vessel wall are calculated based
on the coupling haemodynamic environment including the
intravascular blood flow and the interstitial fluid flow. In
addition, the dynamic changes of vessel diameter and ves-
sel wall permeability are introduced to reflect a series of
pathological characteristics of abnormal blood perfusion in
tumours such as vessel dilation, leakage, cooption, remod-
elling, and collapse.
The simulation focuses on the avascular phase of tumour
development and stops before the emergence of angio-
genesis phase. The results show the oxygen concentration
distribution at different time points of tumour growth. In
addition, the influence of preexisting vessel density on the
oxygen transport has been discussed. In a case of blood-
supply-deficientmicroenvironment, that is, preexisting vessel
network with lowMVD, the significant oxygen consumption
will lead to the uneven distribution of oxygen concentration
through the tumour tissue and eventually upregulate the
hypoxia-induced growth factors such as VEGF to activate
angiogenesis. Compared with the simple treatment of oxygen
transport in which the vessel was treated as point source of
oxygen, the modelling of flow-dependent oxygen transport
can offer more realistic oxygen concentration field since the
blood perfusion is known to be heterogeneous in the tumour
tissue. The proposed model not only provides a quantitative
approach for investigating the interactions between tumour
growth and oxygen delivery, but also is extendable to model
other molecules or chemotherapeutic drug transport in the
future study.
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